Antiarrhythmic Drugs and Cardiac KCa2 Channels

2026-09-23

The reference study used automated whole-cell patch clamp to test whether established antiarrhythmic drugs directly inhibit human KCa2.2 and KCa2.3 channels, an atrial-selective target under investigation for atrial fibrillation. Dronedarone was included in the screen but was not among the compounds showing measurable KCa2 inhibition, while dofetilide and propafenone acted only at concentrations well above their free therapeutic plasma levels.

Pulmonary CRISPR Editing with Lipid Nanoparticles

2026-09-22

The reference study developed biodegradable ionizable lipid nanoparticles that deliver mRNA and CRISPR-Cas9 components to mouse lung epithelium after intratracheal administration. Its high-throughput lipid discovery strategy produced pulmonary transfection substantially stronger than an MC3-based comparator and enabled editing in ciliated and club airway cells, while also identifying important barriers to clinical inhalation.

MnTBAP Chloride: Reading Redox Data in Context

2026-09-22

MnTBAP Chloride is a cell-permeable SOD mimetic for investigating mitochondrial superoxide, inflammation, and stress-related phenotypes. This guide shows how to connect redox, mitochondrial, cytokine, and behavioral readouts without overstating preclinical evidence.

Propidium Iodide in Immune-Cell Fate Assays

2026-09-21

Propidium iodide is a membrane-integrity reporter that adds critical interpretive resolution to immune-cell viability and apoptosis studies. This guide explains how to deploy the DNA intercalating dye in placenta–immune models while separating cell death measurements from mechanistic claims.

MTT Assay: From Metabolic Signal to Mechanism

2026-09-21

MTT, or 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, is more than a viability dye. This guide explains how to use its metabolic signal to design and interpret mechanistic cancer-cell experiments, including the coculture strategy reported for activated mesenchymal stem cells and A549 cells.

HDAC Inhibitors Repress NUT Carcinoma Function

2026-09-20

This study developed a dCas9-based GFP reporter screen to identify small molecules that suppress NUT-driven transcription and uncovered structurally diverse HDAC inhibitors as potent repressors of NUT function. Panobinostat and IRBM6 reduced megadomain-associated oncogenic transcription, promoted differentiation, and restricted tumor growth in xenograft models, supporting chromatin acetylation as a therapeutic vulnerability in NUT carcinoma.

Icatibant in Viral Infections: Evidence and Limits

2026-09-19

This 2023 letter synthesizes case-based experience with icatibant in severe Puumala hantavirus infection and relates it to bradykinin-mediated vascular leakage in COVID-19. Its main contribution is a mechanistic and clinical rationale for early bradykinin receptor blockade, while its small, uncontrolled evidence base means efficacy remains unproven.

MDV3100 and UGDH: Mapping AR Resistance

2026-09-18

MDV3100 (Enzalutamide) research is strengthened by viewing androgen receptor inhibition alongside UGDH-controlled glycan metabolism. This article translates recent mechanistic findings into assay-design principles for studying resistance in prostate cancer models.

U 46619: From TP Signaling to Translation

2026-09-18

U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is a mechanistically useful TP receptor agonist for resolving how platelet activation and vascular responses evolve across exposure levels. This thought-leadership guide connects assay design, renal and blood-pressure models, and anticoagulation strategy while positioning APExBIO product B6890 as a practical research tool.

Restoring PTEN Signaling with Modified mRNA

2026-09-17

PTEN restoration is emerging as a practical strategy for interrogating PI3K/Akt-driven resistance. This thought-leadership article explains how Cap1 and pseudouridine-modified in vitro transcribed mRNA can support controlled PTEN expression, connects nanoparticle delivery evidence to translational study design, and outlines how EZ Cap™ Human PTEN mRNA (ψUTP) can strengthen cancer research workflows without overstating clinical readiness.

Adefovir-Induced Osteochondrosis Mimicking AS

2026-09-17

This case report shows how long-term Adefovir exposure can produce hypophosphatemic osteochondrosis with sacroiliac imaging findings that resemble ankylosing spondylitis. Its practical contribution is a differential-diagnosis framework linking phosphate and alkaline phosphatase testing with medication history, imaging, and improvement after Adefovir withdrawal.

BH3-Mimetic Targeting in Glioblastoma

2026-09-16

The reference study shows that glioblastoma, including stem-like tumor cell populations, depends on the anti-apoptotic proteins BCL-XL and MCL-1. Its central translational insight is that sequential inhibition of these survival proteins can expose apoptotic vulnerability and produce robust anti-tumor responses in vivo without overt toxicity in the reported models.

Basic Protein Native PAGE Kit: K4142 Guide

2026-09-16

5-Methyl-CTP: From IVT to Vaccine Evidence

2026-09-15

Discover how 5-Methyl-CTP supports modified mRNA synthesis and how its performance should be evaluated beyond transcript yield. This evidence-driven guide connects nucleotide chemistry, analytical controls, and mRNA vaccine studies without overstating what animal data prove.

FLAG tag Peptide Workflows for Protein Purification

2026-09-15

Turn a short DYKDDDDK epitope into a practical control point for recombinant protein capture, gentle elution, detection, and antibody validation. This workflow also connects affinity purification with the fast-dissociation antibody screening strategy reported in single-molecule microscopy research.